Lisle Nabell is an Oncology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 218 publications with 5,837 citations (h-index 31); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 30 Jun 2023.
Clinical trials
- Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Sponsor: University of Alabama at Birmingham
- Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Sponsor: University of Alabama at Birmingham
- Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma
Sponsor: University of Alabama at Birmingham
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20251 payment
- Seagen Inc.Program year20211 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2000–2000 per NIH RePORTER. The latest:
- INTRAVENOUS BCX-34 (PELDESINE) IN REFRACTORY T CELL MALI
University of Alabama at Birmingham
FY2000M01RR000032 - SGN-15-DOXORUBICIN IMMUNOCONJUGATE &TAXOTERE IN METATASTIC BREAST AND COLORECTAL
University of Alabama at Birmingham
FY2000M01RR000032
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
Journal of the National Comprehensive Cancer Network
2025 - Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors
Journal of Clinical Oncology
2024 - Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients
Frontiers in Cardiovascular Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”